SUBSCRIBERS
iX Biopharma sinks 9.7% after proposing S$10.2m placement at discount
Published Wed, Jul 29, 2020 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SHARES of pharmaceutical company iX Biopharma sank nearly 10 per cent on Wednesday, after it proposed a private placement of about
44.5 million new ordinary shares at 23 Singapore cents apiece to raise a total of S$10.2 million.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.